Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With Alpha-1 Antitrypsin Deficiency–Associated Liver Disease – The William M. Steinberg Board Review in Gastroenterology and Best Practices Course

LOG IN | PURCHASE | REGISTER FOR 2026 COURSE

You are currently viewing Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With Alpha-1 Antitrypsin Deficiency–Associated Liver Disease

Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With Alpha-1 Antitrypsin Deficiency–Associated Liver Disease

Post author:GIBoardReview.com
Post published:May 27, 2026
Post category:Society Guidelines

X